XIN Meiyi, LIN Yuhong, Z Kai - China Oncology, 2024 - china-oncology.com
Due to the drawbacks of low specificity and high risk of side effects of traditional anti-tumor
treatments in clinical practice, novel anti-tumor immunotherapy has received attention and …